XBiotech USA Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- XBiotech USA's estimated annual revenue is currently $10.9M per year.
- XBiotech USA's estimated revenue per employee is $144,667
- XBiotech USA has 75 Employees.
- XBiotech USA grew their employee count by 12% last year.
- XBiotech USA currently has N/A job openings.
|John Simard||Founder, President, CEO & Chairman|
|Queena Han||Vice President, Finance and Human Resources and Secretary (Principal Financial Officer)|
|Qian Wu||VP of Quality Control|
|Edwin Vera||Facilities Director|
|Rodney Bowling||Director of Molecular Genetics|
|Steve Antonakes||IT Director|
|Sushma Shivaswamy||Chief Scientific Officer|
|Rodney Bowling Jr.||Director of Molecular Genetics|
|Mark Williams||Medical Director|
What Is XBiotech USA?
XBiotech is developing a first-in-class monoclonal antibody (MABp1) to inhibit chronic inflammation. Chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. MABp1 is being investigated in many important areas of medicine, including: cancer, leukemia (Phase 1); Type 2 diabetes (Phase2); Psoriasis (Phase 2); and vascular disease (Phase 2). MABp1 is a True Human antibody cloned from a natural human immune response andunlike currently marketed antibodiesit has not undergone any modification to alter its function. It has exhibited the best potential tolerability and safety during the clinical trials. XBiotech has established a current good manufacturing practices (cGMP) program to commercialize its lead product candidate. The Company has purchased land and designed a commercial-scale plant with 25,000L total bioreactor capacity. Construction of the facility is planned to commence in 4th quarter 2011..keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Family Tree DNA||$5.7M||40||18%||N/A|
XBiotech USA News
XBiotech USA Inc. received the award for its integrated R&D, administrative, and manufacturing facility located just 15 minutes from downtown ...
Global Cancer Cachexia Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use is latest research study ...
A "green living" concept served as the guiding vision of the Southeast Austin campus of biosciences company XBiotech USA Inc.. The $21.4 ...